Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer ...
In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...
Morning Overview on MSN
Tiny eye implant shows promise for restoring vision
A tiny wireless chip placed at the back of the eye is giving people with severe vision loss something they had been told they would never regain: the ability to see letters, shapes and even words ...
A groundbreaking electronic eye implant has offered a ray of hope to patients suffering from age-related macular degeneration (AMD), a leading cause of blindness in older adults. The device has ...
Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with advanced dry macular degeneration. The hair-thin patch replaces damaged retinal ...
An electronic eye implant, thinner than a strand of human hair, is raising hope for millions of older people struggling with vision loss. Jim Carrey Offered to Return $20 Million ‘Grinch’ Payday and ...
The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and ...
Please provide your email address to receive an email when new articles are posted on . Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) is an option after any intraocular surgery ...
TL;DR: Neuralink's former president, Max Hodak, now CEO of Science Corporation, has introduced a new eye implant called Prima, acquired from Pixium Vision. This implant bypasses the retina to directly ...
The US Food and Drug Administration (FDA) has approved an intracameral implant with 75 mcg of travoprost to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular ...
The ranibizumab ocular implant (Susvimo) for neovascular (wet) age-related macular degeneration (nAMD) will return to the U.S. market "in the coming weeks," Genentech announced. The return follows a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results